Table 2.
Semiquantitative PET/CT analysis in 9 men with mCRPC
| Man # | SUV | 18F-NaF- PET/CT Baseline | 18F-NaF- PET/CT Follow-up | 18F-FDG- PET/CT Baseline | 18F-FDG- PET/CT Follow-up |
|---|---|---|---|---|---|
| 1 | SUVmax | 33.1 | 23.5 | Non-avid | Non-avid |
| Average SUVmax | 19.3 | 16.1 | |||
| 2 | SUVmax | 68.8 | 47.1 | Non-avid | Non-avid |
| Average SUVmax | 58.0 | 35.5 | |||
| 3 | SUVmax | 51.2 | 14.3 | 4.9 | 2.9 |
| Average SUVmax | 19.9 | 10.2 | (1 lesion) | (1 lesion) | |
| 4 | SUVmax | 74.0 | 55.8 | 15.6 | 15.8 |
| Average SUVmax | 45.7 | 38.7 | 7.0 | 5.7 | |
| 5 | SUVmax | 33.7 | 32.1 | Non-avid | Non-avid |
| Average SUVmax | 25.8 | 25.5 | |||
| 6 | SUVmax | 61.8 | 59.8 | 7.0 | 9.1 |
| Average SUVmax | 39.4 | 37.6 | (1 lesion) | 6.7 (2 lesions) | |
| 7 | SUVmax | 77.2 | 39.6 | Non-avid | Non-avid |
| Average SUVmax | 40.2 | 16.7 | |||
| 8 | SUVmax | 43.9 | 18.3 | 21.7 | 35.3 |
| Average SUVmax | 37.4 | 14.5 | 15.1 | 13.8 | |
| 9 | SUVmax | 19.1 | 11.6 | Non-avid | Non-avid |
| Average SUVmax | 12.0 | 8.5 |